Suchen
AtriCure Inc
ATRCZur Watchlist hinzufügen
59.955USD
+1.125+1.91%
Handelsschluss 09-23 16:00（ET）
3.05BMarktkapitalisierung
VerlustKGV TTM
Über AtriCure Inc Unternehmen
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
AtriCure Inc Profil
BörsenkürzelATRC
Name des UnternehmensAtriCure Inc
IPO-datumAug 05, 2005
CEOCarrel (Michael H)
Anzahl der mitarbeiter1300
WertpapierartOrdinary Share
GeschäftsjahresendeAug 05
Addresse7555 Innovation Way
StadtMASON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl45040
Telefon15137554100
Websitehttps://www.atricure.com
BörsenkürzelATRC
IPO-datumAug 05, 2005
CEOCarrel (Michael H)
Führungskräfte von AtriCure Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
791.99K
-0.59%
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
791.99K
-0.59%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
147.26K
-7.75%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
147.26K
-7.75%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
100.22K
-6.17%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
100.22K
-6.17%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
87.32K
-10.73%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
87.32K
-10.73%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
791.99K
-0.59%
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
791.99K
-0.59%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
147.26K
-7.75%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
147.26K
-7.75%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von AtriCure Inc?
Die fünf größten Anteilseigner von AtriCure Inc sind: Mr. Michael H. (Mike) Carrel, CPA
Wie viele Institutionen halten Anteile an AtriCure Inc (ATRC)?
Mit Stand vom 2026Q1 halten 505 Institutionen Anteile an AtriCure Inc, mit einem Gesamtmarktwert von etwa 48.18M, was 95.14% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -7010307.00 gestiegen.
Was ist die größte Einnahmequelle von AtriCure Inc?
Am 2026Q1 erzielte das Geschäft mit Appendage Management-United states für AtriCure Inc den höchsten Umsatz in Höhe von 51.61M, was 33.60% des Gesamtumsatzes entspricht.